Redefining cancer characterisation and predisposition insight with nanopore sequencing

In this webinar, Mathilde Filser highlights the game-changing potential for nanopore sequencing to transform molecular analysis in the field of cancer care.
The webinar covers how Mathilde and her team applied nanopore sequencing to detect cancer predisposition genes, as well as profiling structural variants, methylation and copy number variations in cancer patients.